Brom Rector, CFA

Find new targets. Predict the best patients. Know how well new drugs will work, before you begin. Applying transomic technology that uses phosphoproteomic data, Pepper creates treatments for previously untreatable diseases with more informed drug discovery and development.

TARA Mind is a mental health company thats on a mission to expand access to safe, effective, and affordable psychedelic-assisted therapy through a premium provider network of therapists and clinics.

Health is your greatest Superpower. Its time to unlock it.

Motif Neurotech is powered by innovations in efficient wireless power and data, unlocking possibilities for new, miniature implants for tissue stimulation and diagnostic readings.

Pangea Bio is developing novel therapies that directly activate the TrkB receptor, driving neuronal and synaptic plasticity, and neuroprotection. Dysfunction of the BDNF/TrkB pathway is a hallmark of disorders such as schizophrenia, depression, Alzheimer’s disease, Parkinson’s disease, and glaucoma.

XYLO is pioneering neuroplastogens – next-generation therapeutics designed to rewire neural circuits and restore brain function. Combining advanced neuroscience with computational drug discovery, we are developing optimized treatments to revolutionize care for neurological and psychiatric conditions. Our mission is to deliver breakthrough therapies that address critical unmet needs and improve the lives of patients worldwide.

At Lykos Therapeutics, our mission is to transform mental healthcare. We’re applying decades of evidence-based research to develop investigational psychedelics to catalyze therapeutic approaches for mental health conditions. We are relentlessly exploring and reimagining novel approaches to address unmet needs in the mental healthcare space, with an initial focus on PTSD. As a Public Benefit Company, we are focused on delivering positive impact on our people, communities and society. To learn more, visit us at www.lykospbc.com.

We are a clinical stage company developing novel therapeutics inspired by kanna, or Sceletium tortuosum. Kanna is a medicinal succulent traditionally used by the San hunter-gatherers of South Africa.

Freedom Biosciences is a clinical-stage biotechnology platform developing next-generation neuropsychiatric therapeutics. Through its discovery platform, Freedom Biosciences has identified the most efficacious combinations of chemicals to advance the safety and therapeutic profiles of existing therapeutics. With programs with clinical data and multiple exploratory programs, Freedom Biosciences has a diverse portfolio of assets that are positioned to significantly change the way we treat mental health indications. Freedom Biosciences is co-founded by Dr. John Krystal and Dina Burkitbayeva. Dr. John Krystal is the Chair of the Department of Psychiatry at Yale University and Chief of Psychiatry and Behavioral Health at Yale-New Haven Hospital. Dina Burkitbayeva is a co-founder of PsyMed Ventures.

Nue Life is a next-gen mental wellness company that believes in the power of psychedelics to catalyze lasting change.

Mission Control is the platform for when AI Failure is not an option. Our GenOps platform is LLM and AI Agent trust infrastructure SaaS that delivers the missing clarity and security for realizing the potential of AI in the enterprise. Were a leading AI Safety software company. We build the foundational research, scalable software platforms, and global leadership community that accelerates AI trust and safety. Follow us to learn more about the world of AI Safety and our pioneering work: such as the annual Leaders in Responsible AI Summit at Jesus College Cambridge; our monthly newsletter magazine, Accelerate; our forthcoming book, the ABCs of Responsible AI; and our whitepapers and blog posts to keep global private and public sector leaders informed. To find out how Mission Control enables your team to realize the potential of enterprise AI; contact us at usemissioncontrol.com.

Wavepaths unifies immersive arts, psychotherapies and intelligent technologies into a new approach to well-being.

Mindstate Design Labs is a clinical-stage AI neuroengineering platform. Were making every therapeutically valuable emotion available on demand in pharmaceutical form. Our Osmanthus platform is an ensemble of AI models that synthesize the world’s largest datasets of psychoactive pharmacology and phenomenology, quantitatively pinpointing the combination of neurotransmitter receptor activity that underlies various emotional as well as cognitive and perceptual states. Our lead program MSD-001 is designed to be rapid-acting and produce heightened emotional and cognitive flexibility (without hallucinations). MSD-001 is currently in human trials, and will be the base ingredient for multiple drug combination "emotions in a bottle" such as empathy, awe, clarity, or beauty.

Beond treatment is wellness & healing. Psychedelic-assisted treatment for severe Depression, Anxiety, Trauma, Chemical Dependency and Life Optimization.

Find new targets. Predict the best patients. Know how well new drugs will work, before you begin. Applying transomic technology that uses phosphoproteomic data, Pepper creates treatments for previously untreatable diseases with more informed drug discovery and development.

TARA Mind is a mental health company thats on a mission to expand access to safe, effective, and affordable psychedelic-assisted therapy through a premium provider network of therapists and clinics.

Health is your greatest Superpower. Its time to unlock it.

Motif Neurotech is powered by innovations in efficient wireless power and data, unlocking possibilities for new, miniature implants for tissue stimulation and diagnostic readings.

Pangea Bio is developing novel therapies that directly activate the TrkB receptor, driving neuronal and synaptic plasticity, and neuroprotection. Dysfunction of the BDNF/TrkB pathway is a hallmark of disorders such as schizophrenia, depression, Alzheimer’s disease, Parkinson’s disease, and glaucoma.